您的位置： 百康网 > 期刊 > 肿瘤学 > 《肿瘤与内分泌》 > 2006年6月第2期 ·07/06/15 Beyond peroxisome proliferator-activated receptor signaling: the multi-facets of the antitumor effect of thiazolidinediones ·07/06/15 Beyond peroxisome proliferator-activated receptor signaling: the multi-facets of the antitumor effect of thiazolidinediones ·07/06/15 Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA ·07/06/15 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on ·07/06/15 Is oestrogen receptor- ? a predictor of endocrine therapy responsiveness in human breast cancer? ·07/06/15 Molecular links between obesity and breast cancer ·07/06/15 p53 and breast cancer, an update ·07/06/15 Pathogenesis, diagnosis and management of thyroid nodules in children ·07/06/15 The emerging roles of DNA methylation in the clinical management of prostate cancer ·07/06/15 The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs 首 页　上一页 下一页 尾 页　页次：[nowpage]/[countpage]页　[maxpage]篇/页　共 10 篇　转到第 页

栏目导航 ·2005年3月第1期 ·2005年6月第2期 ·2005年9月第3期 ·2005年12月第4期 ·2006年3月第1期 ·2006年6月第2期